SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 1,581.68 |
| Enterprise Value ($M) | 1,305.97 |
| Book Value ($M) | 320.74 |
| Book Value / Share | 1.99 |
| Price / Book | 4.93 |
| NCAV ($M) | 316.81 |
| NCAV / Share | 1.96 |
| Price / NCAV | 4.99 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.91 |
| Return on Assets (ROA) | -0.54 |
| Return on Equity (ROE) | -0.57 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 10.98 |
| Current Ratio | 10.98 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 348.61 |
| Assets | 352.54 |
| Liabilities | 31.80 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Softbank Group Corp | 4.70 | -1.31 | |
| 13G | Berns Paul L | 5.20 | ||
| 13D/A | ARCH Venture Fund XII, L.P. | 20.90 | 7.28 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| Form 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 137,650 | 492,151 | 27.97 | |
| 217,707 | 632,735 | 34.41 | |
| 246,290 | 894,472 | 27.53 | |
| 197,234 | 886,899 | 22.24 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| NBIX – Neurocrine Biosciences, Inc. | NEOG – Neogen Corporation |
| NKTX – Nkarta, Inc. | NUVL – Nuvalent, Inc. |
| NVAX – Novavax, Inc. |
Financial data and stock pages provided by
Fintel.io